Limited time75% off all plans
Get the app

Recurrence risk

On this page

Recurrence Rates - The KD Encore

  • Recurrence vs. Recrudescence

    • Recurrence: A new, distinct episode of Kawasaki Disease (KD) after complete recovery.
    • Recrudescence: Relapse of fever and symptoms within days of initial IVIG, indicating treatment resistance.
  • Incidence & Timeline

    • Overall rate is low: ~1-3%.
    • Most recurrences (>50%) happen within 2 years of the initial episode.
    • Risk may be higher in patients who required a second dose of IVIG.

High-Yield Fact: Patients who develop coronary artery abnormalities (CAA) during their first KD episode are at a significantly higher risk for recurrence compared to those without CAA.

Risk Factors - Predicting a Relapse

  • Host-Related Factors:

    • Male sex
    • Age < 1 year at onset
    • Genetic predisposition (e.g., ITPKC polymorphisms)
  • Treatment & Disease Course:

    • Delayed IVIG therapy (> 10 days of fever)
    • Resistance to initial IVIG treatment
    • Severe initial inflammation (↑ CRP, ↑ ESR)
    • Presence of coronary artery lesions (CALs) during the first episode

⭐ Patients resistant to initial IVIG therapy have a significantly higher risk of developing coronary artery aneurysms and subsequent recurrence.

Diagnosis & Features - Spotting the Sequel

  • High Index of Suspicion: Essential for any patient with a history of Kawasaki Disease (KD) presenting with unexplained fever.

  • AHA Criteria for Recurrence:

    • Unexplained fever reappears and lasts ≥48 hours.
    • Accompanied by ≥3 of the original principal clinical criteria.
    • If fever is present with <3 criteria, evaluate for incomplete recurrent KD.
  • Role of Echocardiography:

    • Absolutely critical at the time of suspected recurrence.
    • Aims to detect new or worsening coronary artery abnormalities (CAA).

⭐ Recurrence risk is highest within the first 2 years of the initial illness and is more common in patients who had cardiac complications initially.

Management - The Retreatment Playbook

  • Standard First-Line: IVIG 2 g/kg as a single infusion + high-dose aspirin.
  • IVIG-Resistant KD: Persistent or recrudescent fever ≥36 hours after initial IVIG.
  • Aspirin Regimen:
    • Anti-inflammatory: 80-100 mg/kg/day until afebrile for 48-72 hrs.
    • Anti-platelet: Taper to 3-5 mg/kg/day for 6-8 weeks (or longer if coronary abnormalities).

⭐ Infliximab (5-10 mg/kg), a TNF-α inhibitor, is a key second-line agent, especially effective in refractory cases and for rapid control of inflammation.

High‑Yield Points - ⚡ Biggest Takeaways

  • Recurrence of Kawasaki Disease (KD) is uncommon (approx. 1-3%), with most cases occurring within 2 years of the initial episode.
  • Major risk factors for recurrence include male sex, age <1 year, and significant cardiac involvement during the first illness.
  • Recurrent episodes are often milder and carry a lower risk of developing new coronary artery aneurysms.
  • Management of a recurrent episode is identical to the primary one: high-dose IVIG and aspirin.

Continue reading on Oncourse

Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.

CONTINUE READING — FREE

or get the app

Rezzy — Oncourse's AI Study Mate

Have doubts about this lesson?

Ask Rezzy, your AI Study Mate, to explain anything you didn't understand

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

START FOR FREE